Reference
1. Townsend N, Wilson L, Bhatnagar P, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J, 2016, 37: 3232-3245.
2. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation, 2017, 135: e146-e603.
3. Shimoni S, Gendelman G, Ayzenberg O, et al. Differential effects of coronary artery stenosis on myocardial function: the value of myocardial strain analysis for the detection of coronary artery disease. J Am Soc Echocardiogr, 2011, 24: 748-757.
4. Wang D, Zhang L, Zeng Q, et al. Assessment of left ventricular performance in heart transplant recipients by three-dimensional speckle tracking imaging. Medicine (Baltimore), 2017, 96: e8129.
5. Nesser HJ, Mor-Avi V, Gorissen W, et al. Quantification of left ventricular volumes using three-dimensional echocardiographic speckle tracking: comparison with MRI. Eur Heart J, 2009, 30: 1565-1573.
6. Zhou Q, Shen J, Liu Y, et al. Assessment of left ventricular systolic function in patients with iron deficiency anemia by three-dimensional speckle-tracking echocardiography. Anatol J Cardiol, 2017, 18: 194-199.
7. Voilliot D, Huttin O, Hammache N, et al. Impact of Global and Segmental Hypertrophy on Two-Dimensional Strain Derived from Three-Dimensional Echocardiography in Hypertrophic Cardiomyopathy: Comparison with Healthy Subjects. J Am Soc Echocardiogr, 2015, 28: 1093-1102.
8. Li L, Zhang PY, Ran H, et al. Evaluation of left ventricular myocardial mechanics by three-dimensional speckle tracking echocardiography in the patients with different graded coronary artery stenosis. Int J Cardiovasc Imaging, 2017, 33: 1513-1520.
9. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J, 2013, 34: 2949-3003.
10. Ryu KS, Park HW, Park SH, et al. Comparison of clinical outcomes between culprit vessel only and multivessel percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel coronary diseases. J Geriatr Cardiol, 2015, 12: 208-217.
11. Solomon SD, Anavekar N, Skali H, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation, 2005, 112: 3738-3744.
12. Yip GW, Zhang Q, Xie JM, et al. Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle-tracking echocardiography. Heart, 2011, 97: 287-294.
13. Langeland S, Wouters PF, Claus P, et al. Experimental assessment of a new research tool for the estimation of two-dimensional myocardial strain. Ultrasound Med Biol, 2006, 32: 1509-1513.
14. Leitman M, Lysyansky P, Sidenko S, et al. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr, 2004, 17: 1021-1029.
15. Biswas M, Sudhakar S, Nanda NC, et al. Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions. Echocardiography, 2013, 30: 88-105.
16. Thebault C, Donal E, Bernard A, et al. Real-time three-dimensional speckle tracking echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. Eur J Echocardiogr, 2011, 12: 26-32.
17. Hayat D, Kloeckner M, Nahum J, et al. Comparison of real-time three-dimensional speckle tracking to magnetic resonance imaging in patients with coronary heart disease. Am J Cardiol, 2012, 109: 180-186.
18. Tee M, Noble JA, Bluemke DA. Imaging techniques for cardiac strain and deformation: comparison of echocardiography, cardiac magnetic resonance and cardiac computed tomography. Expert Rev Cardiovasc Ther, 2013, 11: 221-231.
19. Crosby J, Amundsen BH, Hergum T, et al. 3-D speckle tracking for assessment of regional left ventricular function. Ultrasound Med Biol, 2009, 35: 458-471.
20. Folmes CD, Sowah D, Clanachan AS, et al. High rates of residual fatty acid oxidation during mild ischemia decrease cardiac work and efficiency. J Mol Cell Cardiol, 2009, 47: 142-148.
21. Kane GC, Karon BL, Mahoney DW, et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. Jama, 2011, 306: 856-863.
22. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr, 2016, 29: 277-314.
23. Rydberg E, Willenheimer R, Erhardt L. The prevalence of impaired left ventricular diastolic filling is related to the extent of coronary atherosclerosis in patients with stable coronary artery disease. Coron Artery Dis, 2002, 13: 1-7.
24. Nakatani S. Left ventricular rotation and twist: why should we learn? J Cardiovasc Ultrasound, 2011, 19: 1-6.
25. Goffinet C, Chenot F, Robert A, et al. Assessment of subendocardial vs. subepicardial left ventricular rotation and twist using two-dimensional speckle tracking echocardiography: comparison with tagged cardiac magnetic resonance. Eur Heart J, 2009, 30: 608-617.
26. Reant P, Barbot L, Touche C, et al. Evaluation of global left ventricular systolic function using three-dimensional echocardiography speckle-tracking strain parameters. J Am Soc Echocardiogr, 2012, 25: 68-79.
27. Wang Q, Gao Y, Tan K, et al. Assessment of left ventricular function by three-dimensional speckle-tracking echocardiography in well-treated type 2 diabetes patients with or without hypertension. J Clin Ultrasound, 2015, 43: 502-511.
28. Chan J, Hanekom L, Wong C, et al. Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and long-axis myocardial function. J Am Coll Cardiol, 2006, 48: 2026-2033.
29. Kim HK, Sohn DW, Lee SE, et al. Assessment of left ventricular rotation and torsion with two-dimensional speckle tracking echocardiography. J Am Soc Echocardiogr, 2007, 20: 45-53.
30. Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography–from technical considerations to clinical applications. J Am Soc Echocardiogr, 2007, 20: 234-243.
31. Kraigher-Krainer E, Shah AM, Gupta DK, et al. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol, 2014, 63: 447-456.
32. Mizuguchi Y, Oishi Y, Miyoshi H, et al. The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging. J Am Soc Echocardiogr, 2008, 21: 1138-1144.
33. Nakai H, Takeuchi M, Nishikage T, et al. Effect of aging on twist-displacement loop by 2-dimensional speckle tracking imaging. J Am Soc Echocardiogr, 2006, 19: 880-885.
34. Winter R, Jussila R, Nowak J, et al. Speckle tracking echocardiography is a sensitive tool for the detection of myocardial ischemia: a pilot study from the catheterization laboratory during percutaneous coronary intervention. J Am Soc Echocardiogr, 2007, 20: 974-981.
35. Valli N, Gobinet A, Bordenave L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med, 1999, 134: 437-444.
36. Goetze JP, Jensen G, Moller S, et al. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest, 2006, 36: 8-15.
37. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension, 1991, 17: 1152-1155.
38. Wei G, Yaqi R, Ningfu W, et al. N-terminal prohormone B-type natriuretic peptide and cardiovascular risk in stable coronary artery disease: a meta-analysis of nine prospective studies. Rev Cardiovasc Med, 2013, 14: e92-98.
39. Eliasdottir SB, Klemenzson G, Torfason B, et al. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand, 2008, 52: 182-187.
40. Balta S, Demir M, Demirkol S, et al. Plasma B-type natriuretic peptide level in patients with coronary artery bypass surgery. Kaohsiung J Med Sci, 2013, 29: 648-649.
41. Chen TH, Lin CL, Shih JJ, et al. Plasma B-type natriuretic peptide in predicting outcomes of elective coronary artery bypass surgery. Kaohsiung J Med Sci, 2013, 29: 254-258.